Concepedia

Karen M. McGinn

KM

Statistics

Publications

2

Citations

363

H-Index

2

Active since

2012

Affiliations

Center for Drug Evaluation and Research(Current)

Karen M. McGinn is an author at Center for Drug Evaluation and Research specializing in pharmacotherapy, cancer research, and cancer therapeutics.

Top concepts

Publications per year

2012–2015

2

Publications

2

U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma

R. Angelo de Claro, Karen M. McGinn, Virginia E. Kwitkowski et al. · Clinical Cancer Research · 2012 · 207 citations

, , +12

FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia

R. Angelo de Claro, Karen M. McGinn, Nicole Verdun et al. · Clinical Cancer Research · 2015 · 156 citations

, , +18

1–2 of 2